2015 Fiscal Year Final Research Report
New strategy of treatment for ovarian cancer aiming intraperitoneal cell-cell communication induced by microenvironmental EMT
Project/Area Number |
25293341
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Partial Multi-year Fund |
Section | 一般 |
Research Field |
Obstetrics and gynecology
|
Research Institution | Nagoya University |
Principal Investigator |
Kikkawa Fumitaka 名古屋大学, 医学(系)研究科(研究院), 教授 (40224985)
|
Co-Investigator(Kenkyū-buntansha) |
SHIBATA Kiyosumi 名古屋大学, 大学医学系研究科, 准教授 (90335026)
KAJIYAMA Hiroaki 名古屋大学, 大学医学系研究科, 准教授 (00345886)
|
Co-Investigator(Renkei-kenkyūsha) |
SENGA Takeshi 名古屋大学, 大学医学系研究科, 准教授 (80419431)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Keywords | 卵巣癌 / 腹膜播種 / 腹膜中皮細胞 / 細胞コミュニケーション / 上皮間葉転換 |
Outline of Final Research Achievements |
The TGF-beta;-mediated alteration of the tumor microenvironment plays a crucial role in tumor progression. Mesothelial cells are the primary components of the tumor microenvironment for ovarian cancer cells (OC). We show that TGF-beta;-stimulated human primary mesothelial cells (HPMCs) are able to promote cancer cell attachment and proliferation and the activation of the promoter activities of MMP-2 and MMP-9, which are metalloproteinases necessary for tumor invasion. Expression of the miR-200 family was down-regulated in HPMCs by TGF-beta; stimulation, and restoration of the expression of miR-200 family members in HPMCs suppressed cancer cell attachment and proliferation. Down-regulation of the miR-200 family by TGF-beta; induced fibronectin 1 production, which promoted cancer cell attachment to HPMCs. Finally, we demonstrated that the delivery of the miR-200s to mesothelial cells in mice inhibited ovarian cancer cell implantation and dissemination.
|
Free Research Field |
婦人科腫瘍学
|